Beyond the Impact Factor: An Alternative Approach to Measure the Influence of the Journal Sexually Transmitted Diseases on Sexually Transmitted Infection Prevention and Practice.


Journal

Sexually transmitted diseases
ISSN: 1537-4521
Titre abrégé: Sex Transm Dis
Pays: United States
ID NLM: 7705941

Informations de publication

Date de publication:
01 07 2022
Historique:
pubmed: 22 3 2022
medline: 15 6 2022
entrez: 21 3 2022
Statut: ppublish

Résumé

A journal's quality is often assessed by its impact factor, a measure of the number of times a journal's published articles are cited in the scientific literature. However, the impact factor may not adequately measure a journal's influence on practice. As an alternative approach, we analyzed referenced articles of the 2015 and 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections (STI) Treatment Guidelines, arguably the most influential document on STI prevention and care in the Unites States. Referenced articles in the 2015 and 2021 guidelines were abstracted and analyzed by source and year of publication, and sources were ranked by frequency of citation. Of 892 citations in 2015 and 1454 citations in 2021, the most frequently cited reference sources included the journals Sexually Transmitted Diseases (14.0% and 12.8% in 2015 and 2021, respectively), Clinical Infectious Diseases (7.5% and 8.2%), and Sexually Transmitted Infections (5.6% and 6.4%). Sexually transmitted infection specialty journals influence STI prevention and practice beyond what would be expected from the journals' impact factor alone.

Sections du résumé

BACKGROUND
A journal's quality is often assessed by its impact factor, a measure of the number of times a journal's published articles are cited in the scientific literature. However, the impact factor may not adequately measure a journal's influence on practice. As an alternative approach, we analyzed referenced articles of the 2015 and 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections (STI) Treatment Guidelines, arguably the most influential document on STI prevention and care in the Unites States.
METHODS
Referenced articles in the 2015 and 2021 guidelines were abstracted and analyzed by source and year of publication, and sources were ranked by frequency of citation.
RESULTS
Of 892 citations in 2015 and 1454 citations in 2021, the most frequently cited reference sources included the journals Sexually Transmitted Diseases (14.0% and 12.8% in 2015 and 2021, respectively), Clinical Infectious Diseases (7.5% and 8.2%), and Sexually Transmitted Infections (5.6% and 6.4%).
CONCLUSIONS
Sexually transmitted infection specialty journals influence STI prevention and practice beyond what would be expected from the journals' impact factor alone.

Identifiants

pubmed: 35312672
doi: 10.1097/OLQ.0000000000001628
pii: 00007435-202207000-00001
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

459-461

Informations de copyright

Copyright © 2022 American Sexually Transmitted Diseases Association. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest and Sources of Funding: None declared.

Références

Garfield E. The history and meaning of the journal impact factor. JAMA 2006; 295:90–93. doi:10.1001/jama.295.1.90.
doi: 10.1001/jama.295.1.90
Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Rcomm Rep 2015; 64(RR-03):1–137.
Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep 2021; 70:1–187. doi:10.15585/mmwr.rr7004a1.
doi: 10.15585/mmwr.rr7004a1
Rietmeijer C. Blog Post. Available at: http://www.stdpreventiononline.org/index.php/resources/download/2000 . Accessed September 14, 2021.

Auteurs

Cornelis A Rietmeijer (CA)

From the Rietmeijer Consulting, Denver, CO.

William C Miller (WC)

Department of Epidemiology, Ohio State University, Columbus, OH.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH